Chhatbar aims to contribute significantly to scientific endeavors
Nicoya®, a pioneering life science instrument company specializing in innovative biosensor technology from Ontario, has appointed Medispec as its exclusive distributor in India and to provide cutting-edge research solutions to the scientific community around the globe.
Commenting on the partnership announced on 13 Feb, Nicoya CEO Ryan Denomme said, “We are thrilled to join forces with Medispec to bring our revolutionary biosensor platforms to the dynamic and growing scientific community in India.
“Medispec’s reputation for excellence and commitment to customer success align perfectly with Nicoya’s values, and we are confident that this collaboration will help promote scientific advancements in India.”
Nicoya is renowned for its state-of-the-art Alto™ and OpenSPR® platforms that are designed to accelerate biomolecular interaction studies and lead screening during drug discovery. With a mission to improve human life by helping scientists succeed, Nicoya is excited to collaborate with Medispec to bring its groundbreaking technologies to the Indian market as demand grows.
Medispec Head of Business Development Vikkalp Chhatbar added, “We’re excited to announce this strategic partnership between Medispec and Nicoya, a significant milestone in our commitment to providing the scientific community with the best tools available.
“With the introduction of Nicoya’s innovative biosensor platforms to the Indian market, we aim to contribute significantly to the success of scientific endeavors in India.” Fiinews.com
